Back to results
US 2026/0265746 A1Published application
Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
AssigneeAlnylam Pharmaceuticals, Inc.
InventorsBrian Bettencourt, Kevin Fitzgerald, Stuart Milstein, Martin A. Maier, Klaus Charisse, Kallanthottathil G. Rajeev, Satyanarayana Kuchimanchi, Muthiah Manoharan, Tuyen M. Nguyen
Life of this patent
Estimating the term…
Abstract
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.
Claims25
A double-stranded ribonucleic acid (dsRNA), or a salt thereof, for inhibiting expression of an APOC3 gene,
- wherein the dsRNA comprises a sense strand and an antisense strand forming a double stranded region, wherein the sense strand and the antisense strand are each 30 nucleotides or less in length, and wherein the antisense strand comprises at least 15 contiguous nucleotides from any one of the antisense strand nucleotide sequences in any one of Tables 1, 2, 6, 7, and 10.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.